Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Volgraf

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nature Reviews. Drug Discovery|July 14, 2021
Ligand binding at the protein-lipid interface: strategic considerations for drug designJian Payandeh, Matthew Volgraf
Biochemistry|December 21, 2006
Engineering light-gated ion channelsMatthew R Banghart, Matthew Volgraf, Dirk Trauner
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 15, 2012
Total synthesis of exiguamines A and B inspired by catecholamine chemistryVladimir Sofiyev, Jean-Philip Lumb, Matthew Volgraf, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2007
Mechanisms of photoswitch conjugation and light activation of an ionotropic glutamate receptorPau Gorostiza, Matthew Volgraf, Rika Numano, et al.
Nature Chemical Biology|January 13, 2006
Allosteric control of an ionotropic glutamate receptor with an optical switchMatthew Volgraf, Pau Gorostiza, Rika Numano, et al.
Journal of the American Chemical Society|January 11, 2007
Reversibly caged glutamate: a photochromic agonist of ionotropic glutamate receptorsMatthew Volgraf, Pau Gorostiza, Stephanie Szobota, et al.
Nano Letters|November 24, 2007
All optical interface for parallel, remote, and spatiotemporal control of neuronal activitySheng Wang, Stephanie Szobota, Yuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2009
Nanosculpting reversed wavelength sensitivity into a photoswitchable iGluRRika Numano, Stephanie Szobota, Albert Y Lau, et al.
Nature Chemical Biology|August 5, 2008
Biomimetic synthesis of the IDO inhibitors exiguamine A and BMatthew Volgraf, Jean-Philip Lumb, Harry C Brastianos, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 AntagonistsElisia Villemure, Jack A Terrett, Robin Larouche-Gauthier, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nature Reviews. Drug Discovery|July 14, 2021
Ligand binding at the protein-lipid interface: strategic considerations for drug designJian Payandeh, Matthew Volgraf
Biochemistry|December 21, 2006
Engineering light-gated ion channelsMatthew R Banghart, Matthew Volgraf, Dirk Trauner
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 15, 2012
Total synthesis of exiguamines A and B inspired by catecholamine chemistryVladimir Sofiyev, Jean-Philip Lumb, Matthew Volgraf, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2007
Mechanisms of photoswitch conjugation and light activation of an ionotropic glutamate receptorPau Gorostiza, Matthew Volgraf, Rika Numano, et al.
Nature Chemical Biology|January 13, 2006
Allosteric control of an ionotropic glutamate receptor with an optical switchMatthew Volgraf, Pau Gorostiza, Rika Numano, et al.
Journal of the American Chemical Society|January 11, 2007
Reversibly caged glutamate: a photochromic agonist of ionotropic glutamate receptorsMatthew Volgraf, Pau Gorostiza, Stephanie Szobota, et al.
Nano Letters|November 24, 2007
All optical interface for parallel, remote, and spatiotemporal control of neuronal activitySheng Wang, Stephanie Szobota, Yuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2009
Nanosculpting reversed wavelength sensitivity into a photoswitchable iGluRRika Numano, Stephanie Szobota, Albert Y Lau, et al.
Nature Chemical Biology|August 5, 2008
Biomimetic synthesis of the IDO inhibitors exiguamine A and BMatthew Volgraf, Jean-Philip Lumb, Harry C Brastianos, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 AntagonistsElisia Villemure, Jack A Terrett, Robin Larouche-Gauthier, et al.
Pageof 3